Dados do Resumo

Título

Epidemiological profile: impact of COVID-19 on deaths from Malignant Breast Neoplasms in São Paulo, between 2019 and 2023

Introdução

In Brazil, breast neoplasms are the most prevalent among women, according to the National Cancer Institute. The Southeast region has the highest incidence rates, with São Paulo leading. The Coronavirus disease (COVID-19) is caused by the SARS-CoV-2 virus, and COVID-19 pandemic that presents a challenge on the health worldwide and economy. Due to the prognosis of the breast neoplasms, it is understood why screening is essential, a limiting factor during the COVID-19 pandemic.

Objetivo

To analyze the impact of the COVID-19 pandemic on deaths from Malignant Breast Neoplasm in the city of São Paulo between 2019 and 2023.

Métodos

For this observational epidemiological study, data available at the Department of Information and IT of the Unified Health System (DATASUS) was interpreted on the Tabnet platform using the SUS hospital morbidity descriptor (SHI/SUS). With this, the epidemiological profile of deaths from covid-19 and breast neoplasms in São Paulo between 2019 and 2013 was established by applying the filters: Color/race: white, black, the available information was analyzed and the results exposed in this analysis. Brown, yellow, indigenous and no information, Sex : male and female, Age group, ICD 10 - malignant breast neoplasm and Type of care: urgent and elective. The available information was analyzed and the results exposed in this analysis.

Resultados

Between 2019 and 2023, São Paulo recorded 3,032 deaths from breast neoplasms, with a predominance in white individuals (54.7%), followed by mixed-race (29.3%), black (8.9%), and yellow (1.1%) individuals. The high proportion of cases with missing race information (6%) may limit epidemiological analysis. Mortality was predominantly female (99.3%), with 22 deaths among males. The highest mortality occurred between the ages of 50 and 69, with peaks in 2019 (21.4%) and 2021 (21.1%), followed by a decrease through 2023 (16.9%). Most deaths (94.6%) were from urgent care settings. The significant reduction in deaths in 2023 may reflect the impact of public health interventions and improvements in early diagnosis, as well as the influence of the COVID-19 pandemic, which may have initially reduced the detection and treatment of breast neoplasm cases.

Conclusões

The COVID-19 pandemic impacted breast neoplasm mortality in São Paulo (2019-2023), with peaks in 2019 and 2021. The decrease in 2023 suggests healthcare service recovery and improvements in early diagnosis. The high proportion of deaths in urgent care and the lack of adequate racial data highlight ongoing challenges in health equity and access to timely care. Strengthening screening programs and healthcare resilience is crucial in the face of future public health crises.

Palavras Chave

Epidemiology; Neoplasms; COVID-19